Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes

S S Rathore1, A K Berger, K P Weinfurt

  • 1Clinical Economics Research Unit, Georgetown University Medical Center, Washington, DC 20007, USA.

Circulation
|March 7, 2000
PubMed
Abstract

Insights

Atrial fibrillation (AF) is a common complication of acute myocardial infarction (MI) in elderly patients. Developing AF during hospitalization significantly increases mortality risk following MI.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Public Health

Background:

  • Atrial fibrillation (AF) is a frequent complication following acute myocardial infarction (MI).
  • Patient characteristics and outcomes associated with AF in elderly patients post-MI are not well-defined.
  • Understanding AF's impact in this demographic is crucial for improving care.

Purpose of the Study:

  • To determine the prevalence of AF in elderly patients experiencing acute MI.
  • To investigate the prognostic significance of AF complicating acute MI in this population.
  • To identify predictors of AF and its impact on mortality.

Main Methods:

  • Analysis of 106,780 Medicare beneficiaries aged 65+ treated for acute MI (1994-1996).
  • Categorization of patients based on AF presence (on arrival vs. developed during hospitalization).
  • Logistic regression and Kaplan-Meier survival analyses to assess AF's impact on outcomes.

Main Results:

  • AF was documented in 22.1% of elderly acute MI patients (11,510 presented with AF, 12,055 developed AF).
  • AF patients were older, had more heart failure, and higher rates of prior MI and revascularization.
  • AF independently predicted higher in-hospital, 30-day, and 1-year mortality (ORs ranging from 1.20 to 1.34).
  • Patients developing AF during hospitalization had a worse prognosis than those presenting with AF.

Conclusions:

  • Atrial fibrillation is a common complication of acute MI in the elderly.
  • AF independently increases mortality risk in elderly patients post-MI.
  • The timing of AF development (during hospitalization) is a critical factor influencing prognosis.

Related Concept Videos

Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
5.5K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
954
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
598
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
1.2K